Materias dentro de su búsqueda.
Mostrando 14,321 - 14,340 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.35s Limitar resultados
  1. 14321
    “…We have previously reported that the proanthocyanidin (PAC) fraction in blueberry (BB) leaves has strong antiviral activity against hepatitis C virus (HCV) and human T-lymphocytic leukemia virus type 1 (HTLV-1). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes
  2. 14322
    “…METHODS: Sixty‐nine surgically resected HCCs from patients with hepatitis C virus infection were analyzed by gene expression profiling and whole‐exome sequencing. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatocellular carcinoma after a sustained virological response by direct‐acting antivirals harbors TP53 inactivation
  3. 14323
    “…METHODS: This study included 51 patients with liver cirrhosis, 51 patients with HCC on top of hepatitis C virus (HCV) infection, and 50 healthy controls. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Detection of exosomal miR-18a and miR-222 levels in Egyptian patients with hepatic cirrhosis and hepatocellular carcinoma
  4. 14324
    “…Background: The hepatitis C virus has a high mutation rate, which results in the emergence of resistance-associated substitutions (RASs). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals
  5. 14325
    “…Alcohol (43.4%) and chronic hepatitis C (18.6%) were the most frequent causes of liver transplantation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Antibody response to the messenger RNA‐1273 vaccine (Moderna) in liver transplant recipients
  6. 14326
    “…RESULTS: In the adult recipients, the primary diagnoses were hepatitis B virus (HBV)-associated liver cirrhosis (n=1,898, 62.9%), alcoholic liver disease (n=482, 16.0%), hepatitis C virus-associated cirrhosis (n=203, 6.7%), acute liver failure (n=127, n=4.2%), and other diseases (n=157, 5.2%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Changes in the indications for living donor liver transplantation: single-institution experience of 3,145 cases over 10 years
  7. 14327
    “…Significant liver fibrosis regression occurs after hepatitis C virus (HCV) therapy. However, the impact of direct-acting antivirals (DAAs) on steatosis is less clear. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants
  8. 14328
    “…BACKGROUND: Hepatitis C virus self-testing (HCVST) may increase test uptake especially among marginalized key populations such as men who have sex with men (MSM). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HCV Self-Testing to Expand Testing: A Pilot Among Men Who Have Sex With Men in China
  9. 14329
    “…Indications for the use of the basiliximab protocol were as follows: patients over the age of 70 years, history of cancer, hepatitis C virus or human immunodeficiency virus infection history, and cytomegalovirus or Epstein-Barr virus (donor positive/ recipient negative). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
  10. 14330
    “…We found increased SELPLG expression in Hepatitis C-specific CD8(+) T cells in patients with chronic infection, whereas these levels were decreased in patients that resolved the infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells
  11. 14331
    “…BACKGROUND: Many women living with HIV (WLHIV) are co-infected with cytomegalovirus (CMV), Toxoplasma gondii (T gondii), and/or hepatitis C virus (HCV). The rates of congenital or perinatal transmission of these co-infections are not well defined in the current era, when most WLHIV receive antiretroviral therapy (ART) during pregnancy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Congenital Co-infections Among HIV-Exposed Infants Born to Mothers on Antiretroviral Treatment in the United States
  12. 14332
    “…Achieving global elimination of hepatitis C virus requires a substantial scale‐up of testing. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Determining the lower limit of detection required for HCV viral load assay for test of cure following direct‐acting antiviral‐based treatment regimens: Evidence from a global data set
  13. 14333
    “…PURPOSE: In the last two decades transmission of hepatitis C virus (HCV) in HIV positive men who have sex with men (MSM) has been reported globally. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Risk factors for HCV transmission in HIV-positive men who have sex with men in México
  14. 14334
    “…BACKGROUND: Hepatitis C virus (HCV) is a common cause of progressive hepatic fibrosis, cirrhosis, and hepatocellular carcinoma worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial
  15. 14335
    “…BACKGROUND: Sofosbuvir, a prodrug nucleoside inhibitor of hepatitis C virus, has a predominant circulating metabolite that is renally eliminated. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sofosbuvir and risk of estimated glomerular filtration rate decline or end‐stage renal disease in patients with renal impairment
  16. 14336
    “…Another Flaviviridae, hepatitis C virus, is highly dependent on apolipoprotein E (ApoE) for the completion of its infectious cycle. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The envelope protein of Zika virus interacts with apolipoprotein E early in the infectious cycle and this interaction is conserved on the secreted viral particles
  17. 14337
    “…BACKGROUND: People who inject drugs (PWID) are at an amplified vulnerability for experiencing a multitude of harms related to their substance use, including viral (e.g. HIV, Hepatitis C) and bacterial infections (e.g. endocarditis). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Application of machine learning algorithms for localized syringe services program policy implementation – Florida, 2017
  18. 14338
    por Maia, Israel Silva, Marcadenti, Aline, Zampieri, Fernando Godinho, Damiani, Lucas Petri, Santos, Renato Hideo Nakagawa, Negrelli, Karina Leal, Gomes, Samara Pinheiro do Carmo, Gomes, Jaqueline Oliveira, Carollo, Mariana Barbosa dos Santos, Miranda, Tamiris Abait, Santucci, Eliana, Valeis, Nanci, Laranjeira, Ligia Nasi, Westphal, Glauco Adrieno, Horta, Jacques Gabriel Alvares, Flato, Uri Adrian Prync, Fernandes, Camilo, Barros, Waldemar Carlos, Bolan, Renata S, Gebara, Otávio Celso Eluf, de Alencar Filho, Meton Soares, Hamamoto, Victor Augusto, Hernandes, Mauro Esteves, Golin, Nicole Alberti, de Olinda, Ronald Torres, Machado, Flávia Ribeiro, Rosa, Régis Goulart, Veiga, Viviane Cordeiro, de Azevedo, Luciano César Pontes, Avezum, Alvaro, Lopes, Renato Delascio, Souza, Tiago Moreno L, Berwanger, Otávio, Cavalcanti, Alexandre Biasi
    Publicado 2022
    “…The REVOLUTIOn trial has the objective of evaluating three repurposed antiviral drugs, atazanavir, daclatasvir and sofosbuvir, already used for HIV- and hepatitis C virus-infected patients in a randomized, placebo-controlled, adaptive, multiarm, multistage study. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Antivirals for adult patients hospitalized with SARS-CoV-2 infection: A randomized, Phase II/III, multicenter, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX – REVOLUTIOn: protocol and statistical analysis plan
  19. 14339
    “…This study quantifies the impact of COVID-19 in the screening program of chronic viral infections such as human papillomavirus (HPV), human immunodeficiency virus (HIV), and hepatitis C virus (HCV) along the six different pandemic waves in our population. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Negative Impact of COVID-19 in HCV, HIV, and HPV Surveillance Programs During the Different Pandemic Waves
  20. 14340
    “…LAY SUMMARY: The EASL multinational survey conclusively shows that viral hepatitis elimination programs, expected to provide control of hepatitis B and hepatitis C worldwide by 2030, have been held back by the COVID-19 pandemic in clinical centers from several European and non-European countries, with a comparable impact across centers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey
Herramientas de búsqueda: RSS